ESR1 and breast carcinoma: Reduced expression of the glucocorticoid receptor due to promoter hypermethylation was observed in breast cancer samples, and particularly, but not exclusively, in ER-positive tumors, but this is likely enough to influence GC responsiveness in the tumor cells [72].